Generative AI Healthcare Agent
First written in FY2025-H1. 1 of 3 entries say "Advanced", first in FY2025. Latest entry: FY2026-H1.
No other company in this theme has enough history to compare yet.
- FY2026-H1Reassessment of recovering upfront costs; extraordinary loss recordedAnnual report
「In light of recent changes in the operating environment, we reassessed the recoverability of costs paid in advance by the Company to Hippocratic AI, Inc. and recorded ¥65,790 thousand as an extraordinary loss.」
The recoverability of upfront payments to Hippocratic AI, Inc. was reassessed in light of changes in the operating environment, and an extraordinary loss of ¥65,790 thousand, including contract termination losses, was recorded. The disclosure does not state that development of the agent itself was discontinued. - FY2025AdvancedAnnual report
「Together with Hippocratic AI, Inc., which develops and provides generative AI healthcare agents globally, including in the United States, we began developing an interactive generative AI healthcare agent capable of communicating in Japanese in the healthcare field.」
Joint development with Hippocratic AI began for a Japanese-language interactive generative AI healthcare agent. Group-wide R&D expenses were ¥143,946 thousand, of which ¥78,161 thousand related to the agent. - FY2025-H1First statedAnnual report
「As a Group-wide initiative, we entered into a capital and business alliance agreement with Hippocratic AI, Inc. and began developing a generative AI healthcare agent that converses with patients without providing diagnoses. R&D expenses for these initiatives amounted to ¥41,314 thousand.」
The Group began developing a generative AI healthcare agent that converses with patients without providing diagnoses through a capital and business alliance with Hippocratic AI. R&D expenses were ¥41,314 thousand.